VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $12,000 | 0.0% | 510 | -36.3% | 0.00% | – |
| Q1 2018 | $12,000 | -78.9% | 801 | -70.9% | 0.00% | – |
| Q4 2017 | $57,000 | +128.0% | 2,753 | +60.6% | 0.00% | – |
| Q3 2017 | $25,000 | +525.0% | 1,714 | +626.3% | 0.00% | – |
| Q2 2017 | $4,000 | – | 236 | +521.1% | 0.00% | – |
| Q1 2017 | $0 | – | 38 | +90.0% | 0.00% | – |
| Q4 2016 | $0 | – | 20 | +66.7% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 12 | -100.0% | 0.00% | -100.0% |
| Q1 2016 | $7,465,000 | -76.8% | 283,841 | -10.4% | 0.05% | -76.5% |
| Q4 2015 | $32,212,000 | -27.5% | 316,898 | +27.3% | 0.20% | -52.0% |
| Q3 2015 | $44,421,000 | +6.3% | 249,025 | +24.1% | 0.41% | +7.9% |
| Q2 2015 | $41,770,000 | +10.1% | 200,699 | +5.1% | 0.38% | +14.5% |
| Q1 2015 | $37,948,000 | +255.8% | 191,042 | +156.3% | 0.33% | +251.1% |
| Q4 2014 | $10,667,000 | – | 74,529 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |